Patent Yard Sign in
Canadian application, no grantCanada

Anti-gpiib/iiia recombinant antibodies

CA 2293693 A1 · Owner: Berchtold, Peter · Inventors: Escher, Robert F.A.; Berchtold, Peter

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to novel nucleic acid sequences which code for human auto-antibodies and anti-idiotypic antibodies against blood platelet membrane proteins. The invention also relates to new amino acid sequences of human antibodies and to the use thereof in the diagnosis and therapy of diseases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 5, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 5, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 5, 1998
GrantedNo grant recorded
Term endedJune 5, 2018
Patent numberCA 2293693 A1
Classification (IPC)C12N15/13 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedJune 5, 1998Term endedJune 5, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.